Farewell to exogenous surfactant therapy in acute lung injury/acute respiratory distress syndrome! Or, must we start all over again?
Kesecioglu
Jozef
J
D055371:Acute Lung Injury / Q000188:drug therapy* / Q000503:physiopathology; D000280:Administration, Inhalation; D000336:Aerosols; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D011208:Powders; D037721:Pulmonary Surfactant-Associated Protein C / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use
D000336:Aerosols; D011208:Powders; D037721:Pulmonary Surfactant-Associated Protein C; D011994:Recombinant Proteins